Advertisement

nCoV vaccine: Trials of Sputnik V begin in India

Follow The Hawk on Google News+ Follow

Advertisement


New Delhi: Russian Sputnik V vaccine against COVID-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organization's Drug Controller General (DCGI) has said.

The organisation has granted permission for conducting the tests to pharmaceutical giant Dr Reddy's Laboratories.

Advertisement

The date and timing of the testing will be determined by the company, the DCGI said.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

The vaccine will be tested in the second phase of its clinical trials before moving on to phase 3.

Last week, the Russian Direct Investment Fund (RDIF) and Dr Reddy's said that they had received approval from the DCGI to conduct phase 2 and 3 of clinical trials of Sputnik V. The RDIF and Dr Reddy's have entered into a partnership to supply the Indian company with 100 million doses of Sputnik V in September.

Advertisement

On Monday, the RDIF and another Indian pharmaceutical company, Mankind Pharma, signed an agreement for the marketing and distribution of Sputnik V.

Russia registered the world's first coronavirus vaccine, developed by the Gamaleya Institute together with RDIF, in August. The fund has been teaming up with partners to conduct Sputnik V clinical trials in Belarus, Venezuela and the United Arab Emirates.

—UNI

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST